Clinical Trial Highlights

• Rivaroxaban Improves Outcomes in Patients with Acute Coronary Syndromes
• Escalating Clopidogrel by Involving a Genetic Strategy-TIMI 56
• Results from the PALLAS Study: Using Dronedarone on Top of Standard Therapy
• Extended Apixaban Failed to Reduce VTE Risk in Medically Ill Patients
• Results from the TRA•CER Trial
• ISAR-REACT 4 – Bivalirudin Similar to Abciximab/Heparin in Reducing Ischemic Outcomes in NSTEMI and Has Significantly Less Bleeding
• CETP Inhibitor Evacetrapib Reduces LDL-C and Raises HDL-C Levels
• AIM-HIGH: Niacin Provides No Added Benefit for Statin Users with Well-Controlled LDL
• Free Post-MI Medications Improve Adherence without Added Costs
• C-PORT E: Elective PCI Safe in Hospitals with No Cardiac Surgery Support